Ursodeoxycholic Acid as add-on Therapy in Type 2 Diabetes Mellitus
Status:
Recruiting
Trial end date:
2024-11-28
Target enrollment:
Participant gender:
Summary
Diabetes mellitus (DM) is a complex metabolic disorder characterized by hyperglycemia and
abnormalities in carbohydrate, fat, and protein metabolism. It is one of the most prevalent
metabolic disorders globally. Despite the advancement in anti-diabetic drug therapy, most
patients fail to achieve optimal glycemic control. therefore, there is a large unmet need to
develop new strategies to improve the therapeutic outcomes in diabetic patients. This study
is designed to evaluate the efficacy of ursodeoxycholic acid as adjunctive therapy in
patients with type 2 diabetes mellitus.